Jailendra Singh
Stock Analyst at Truist Securities
(0.82)
# 3,835
Out of 4,944 analysts
182
Total ratings
24.21%
Success rate
-23.19%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $176.29 | +32.74% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $468.00 | -6.84% | 5 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $209 → $235 | $190.23 | +23.53% | 16 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $35.35 | +44.27% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $23.06 | +17.09% | 10 | Jul 17, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $45 → $48 | $48.33 | -0.68% | 10 | Jul 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $16 | $8.97 | +78.37% | 6 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $64.02 | -4.72% | 9 | Jul 17, 2025 | |
| HNGE Hinge Health | Initiates: Buy | $48 | $58.05 | -17.31% | 1 | Jun 16, 2025 | |
| PHR Phreesia | Maintains: Buy | $34 → $35 | $28.65 | +22.16% | 6 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $7.44 | +20.97% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $21.02 | +33.21% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $3.56 | +54.49% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $7.19 | +4.31% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $29.69 | +54.93% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $279.18 | -24.78% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $12.83 | +9.12% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $1.05 | +519.05% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $3.59 | +262.12% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $5.33 | +706.75% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.94 | +509.14% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.08 | +92.31% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $148.12 | -60.84% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $6.03 | +646.27% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $663.17 | -49.79% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.62 | +243.51% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $24.53 | - | 3 | Jan 15, 2021 |
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $176.29
Upside: +32.74%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $468.00
Upside: -6.84%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $209 → $235
Current: $190.23
Upside: +23.53%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $35.35
Upside: +44.27%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $23.06
Upside: +17.09%
Hims & Hers Health
Jul 17, 2025
Maintains: Hold
Price Target: $45 → $48
Current: $48.33
Upside: -0.68%
Evolent Health
Jul 17, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $8.97
Upside: +78.37%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $64.02
Upside: -4.72%
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $58.05
Upside: -17.31%
Phreesia
May 29, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $28.65
Upside: +22.16%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $7.44
Upside: +20.97%
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $21.02
Upside: +33.21%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $3.56
Upside: +54.49%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $7.19
Upside: +4.31%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $29.69
Upside: +54.93%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $279.18
Upside: -24.78%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $12.83
Upside: +9.12%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $1.05
Upside: +519.05%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $3.59
Upside: +262.12%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $5.33
Upside: +706.75%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.94
Upside: +509.14%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.08
Upside: +92.31%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $148.12
Upside: -60.84%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $6.03
Upside: +646.27%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $663.17
Upside: -49.79%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.62
Upside: +243.51%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $24.53
Upside: -